PRODUCT LITERATURE

Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions

---

This study was a randomized, single- blind, two-period, cross-over study which included 24 healthy adult male and female subjects under fasting conditions. The pharmacokinetic parameters were determined based on the concentrations of candesartan (CAS 139481-59-7), using ultra-pressure high-performance liquid chromatography with a tandem mass spectrometer detector. In each of the two study periods (separated by a washout period of 1 week), a single dose of test or reference product was administered. The pharmacokinetic parameters assessed were area under the plasma concentration time curve (AUC) from time 0 hours to 24 hours, AUC from time zero to infinity, the peak plasma concentration of the drug (Cmax), time to achieve the Cmax, and the elimination half-life

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Canderin
Candesartan
Bioequivalence
angiotensin-2 receptor antagonist

Specific Detail Info

Drug Design, Development and Therapy 2013:7 841–847

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment